WCN26-3140 PROSPECTIVE STUDY ON DARATUMUMAB WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) DISEASES

Read full text Summarise with VIRAT
Authors: Minna Seppälä, Marja Kovala, Eero Olavi Honkanen, Anne K Räisänen-Sokolowski, S. Meri, Juha Matti Lievonen, Sauli Vuoti, Hannah Söderholm, Sini Luoma, Piia Matikainen, Heli Uotinen, Minna Lehto
+3 more Sorella Ilveskero, Samuli Rounioja, Kati Kaartinen
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Kidney diseases caused by monoclonal gammopathy not fulfilling criteria of overt hematological malignancy are grouped under the term monoclonal gammopathy of renal significance (MGRS). Kidney biopsy is mandatory to make the diagnosis.

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Renal Diseases and Glomerulopathies Amyloidosis: Diagnosis Treatment Outcomes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105728–105728
Publication date
25 March 2026
Language
EN